ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 73. Num. 2.
Pages 190 (February 2020)

Corrections
Correction in article by Santas et al. “International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists”, Rev Esp Cardiol. 2019;72:616-624

Corrección en el artículo de Santas et al. «Razón internacional normalizada y mortalidad de los pacientes con insuficiencia cardiaca y fibrilación auricular tratados con antagonistas de la vitamina K», Rev Esp Cardiol. 2019;72:616-624

Rev Esp Cardiol. 2019;72:616-2410.1016/j.rec.2018.07.010
Enrique Santas, Gema Miñana, Jana Gummel, Roxana Farcasan, Ana Payá, Raquel Heredia, Vicent Bodí, Anna Mollar, Vicente Bertomeu-González, Francisco Javier Chorro, Juan Sanchis, Josep Lupón, Antoni Bayés Genís, Julio Núñez

Options

An error has been detected in figure 1 of the article by Santas et al. “International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists”. Where the text stated “INR>2”, it should have read “INR>3”. The corrected figure 1 is shown below:

Figure 1
(0.13MB).

This correction was introduced into the online version of the article on October 21, 2019.

Copyright © 2020. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?